Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Bremer

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Trends in Molecular Medicine|June 27, 2006
Targeted induction of apoptosis for cancer therapy: current progress and prospectsEdwin Bremer, Go van Dam, Bart Jan Kroesen, et al.
Cancers|July 9, 2022
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR SignalingVrouyr Bilemjian, Martijn R Vlaming, Jimena Álvarez Freile, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cellsEdwin Bremer, Douwe Samplonius, Bart-Jan Kroesen, et al.
Blood|December 8, 2005
CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemiaEdwin Bremer, Bram ten Cate, Douwe F Samplonius, et al.
Immunologic Research|June 25, 2025
High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosisNienke Visser, Nisha K van der Meer, Yuan He, et al.
Frontiers in Immunology|August 10, 2023
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for <i>in vitro</i> screening of immunomodulatory checkpoints and therapeuticsJimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
EpCAM in morphogenesisMonika Trzpis, Edwin Bremer, Pamela M J McLaughlin, et al.
The Journal of Investigative Dermatology|May 26, 2019
Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint BlockadeIris Koopmans, Mark A J M Hendriks, Robert J van Ginkel, et al.
Chembiochem : a European Journal of Chemical Biology|January 18, 2024
Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific AntibodiesVrouyr Bilemjian, Yusheng Lin, Wei Wan, et al.
Cell Death Discovery|June 30, 2023
Notch1 promotes resistance to cisplatin by up-regulating Ecto-5'-nucleotidase (CD73) in triple-negative breast cancer cellsYuzhu Qi, Meifang Li, Shaozhong Li, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Trends in Molecular Medicine|June 27, 2006
Targeted induction of apoptosis for cancer therapy: current progress and prospectsEdwin Bremer, Go van Dam, Bart Jan Kroesen, et al.
Cancers|July 9, 2022
The Novel Immune Checkpoint GPR56 Is Expressed on Tumor-Infiltrating Lymphocytes and Selectively Upregulated upon TCR SignalingVrouyr Bilemjian, Martijn R Vlaming, Jimena Álvarez Freile, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Exceptionally potent anti-tumor bystander activity of an scFv:sTRAIL fusion protein with specificity for EGP2 toward target antigen-negative tumor cellsEdwin Bremer, Douwe Samplonius, Bart-Jan Kroesen, et al.
Blood|December 8, 2005
CD7-restricted activation of Fas-mediated apoptosis: a novel therapeutic approach for acute T-cell leukemiaEdwin Bremer, Bram ten Cate, Douwe F Samplonius, et al.
Immunologic Research|June 25, 2025
High expression of signal regulatory protein beta 2 marks a favourable prognostic AML subgroup and associates with increased sensitivity to phagocytosisNienke Visser, Nisha K van der Meer, Yuan He, et al.
Frontiers in Immunology|August 10, 2023
A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for <i>in vitro</i> screening of immunomodulatory checkpoints and therapeuticsJimena Álvarez Freile, Yuzhu Qi, Lisa Jacob, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
EpCAM in morphogenesisMonika Trzpis, Edwin Bremer, Pamela M J McLaughlin, et al.
The Journal of Investigative Dermatology|May 26, 2019
Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint BlockadeIris Koopmans, Mark A J M Hendriks, Robert J van Ginkel, et al.
Chembiochem : a European Journal of Chemical Biology|January 18, 2024
Direct Functionalization of Polysaccharide-Based Xylan Phenyl Carbonate Nanoparticles with Tumor Cell Specific AntibodiesVrouyr Bilemjian, Yusheng Lin, Wei Wan, et al.
Cell Death Discovery|June 30, 2023
Notch1 promotes resistance to cisplatin by up-regulating Ecto-5'-nucleotidase (CD73) in triple-negative breast cancer cellsYuzhu Qi, Meifang Li, Shaozhong Li, et al.
Pageof 10